Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 596 of 1,261
  1. US 9820955

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  2. US 9822089

    R type of resveratrol dimer, preparation process therefor and purpose thereof in lowering blood sugar level

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  3. US 9820964

    Ultrapure tetrahydrocannabinol-11-oic acids

    Corbus Pharmaceuticals, Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  4. US 9820957

    Methods of treating autoimmunity

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  5. US 9820653

    Methods, systems, and devices for imaging microscopic tumors

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  6. US 9822057

    Solid forms of treprostinil

    United Therapeutics Corporation · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  7. WO 2017194692

    DERIVES DE LA BENZOXAZINE OU DE LA QUINAZOLINE POUR LEUR UTILISATION DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    BIOCODEX [FR] · Granted Nov 16, 2017 · Expires Nov 11, 2037

    granted
  8. US 9815850

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  9. US 9816046

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  10. US 9814755

    Methods for the treatment of depression and anxiety

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  11. US 9814706

    Hydrobromide salt of pridopidine

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  12. US 9816092

    Modulation of transthyretin expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  13. US 9814789

    Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

    Julius-Maximilians-Universitat Wurzburg · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  14. US 9815796

    Pyrimidone carboxamide compounds as PDE2 inhibitors

    MSD R&D (China) Co. Ltd. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  15. US 9815814

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  16. US 9814422

    Compositions for solubilizing cells and/or tissue

    The Regents of the University of California · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  17. US 9815872

    Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  18. US 9814729

    Nerve agent antidotes

    The Regents of the University of California · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  19. US 9816075

    Compounds with modifying activity enhanced under hypoxic conditions

    The Board of Regents of the University of Texas System · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  20. US 9816078

    Compositions for increasing polypeptide stability and activity, and related methods

    Solis BioDyne OÜ · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  21. US 9815890

    Antibodies to the C3d fragment of complement component 3

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  22. US 9816066

    Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters

    The Regents of the University of California · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  23. US 9815887

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  24. US 9815938

    Production method for poly(amino acid)

    Takeda Pharmaceutical Company Limited · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.